ISSN   0974-3618  (Print)                    www.rjptonline.org

            0974-360X (Online)

 

 

RESEARCH ARTICLE

Preparation and Evaluation of Phytosomes of Pomegrane Peels

 

Pande S. D.1*, Wagh A.S.2 , Bhagure L.B.1, Patil S.G.2 , Deshmukh A.R.1

1Dr. Vedprakash Patil Pharmacy College, Aurangabad.

2School of Pharmacy, S R T M University, Nanded.

*Corresponding Author E-mail: shitalpande08@gmail.com

 

ABSTRACT:

Natural plant extracts and phytoconstituents have excellent bioactivity in-vitro but less in-vivo due to their poor lipid solubility or multiple ring large molecules or destruction in gut. Novel drug delivery system phytosomes were prepared by complexing polyphenolic phyto- constituents with phospholipid mainly phosphatidylcholine which bind components to each other on a molecular level. Bioavailability is enhanced due to their capacity to cross the lipid rich bio-membranes and to protect the valuable components of the herbal extract from destruction by digestive secretions and gut bacteria. Phytosomes have the capacity to deliver the standardized plant extracts and phytoconstituents through several routes of drug administration which increases the bio-availability of the herbal formulation. The present study directed toward the development and evaluation of phytosomes of Pomegranate peels. The physicochemical properties of the prepared complex were analyzed by ultraviolet-visible spectrometry (UV), infrared spectrometry (IR) and differential scanning calorimetry (DSC), in-vitro dissolution study etc. The result showed that methanolic extract and phospholipids in Methanolic extract -phospholipids complex were joined by non-covalent bond and did not form a new compound. Prepared pomegranate peel phytosomes showed better bioavailability.

 

KEYWORDS: Phospholipids, Pomegranate peels, Phytosomes, Methanolic extracts, Complex.

 

 


INTRODUCTION:

During the last century chemical and pharmacological studies have been performed on a lot of plant extracts in order to know their chemical composition and confirm the indications of traditional medicine. Preparations of Phyto medicine has been used for health maintenance since ancient times. The Phytomedicines posses a lot of therapeutic uses. It is observed that most of the biologically active phytoconstituents such as the flavonoids and terpenoids are of highly polar nature or water soluble molecules. These highly water soluble constituents are poorly absorbed due to their poor lipid solubility, thus creating a hurdle to cross the highly lipid-rich biological membrane, which finally results in poor bioavailability. Many approaches have been developed for improving the bioavailability such as inclusion of solubility and bioavailability enhancers, structural modification and entrapment with lipophilic carriers.[1]

 

 

Received on 02.01.2015       Modified on 09.01.2015

Accepted on 20.01.2015      © RJPT All right reserved

Research J. Pharm. and Tech. 8(4): April, 2015; Page 416-422

DOI: 10.5958/0974-360X.2015.00070.0

“Phytosomes” are novel phytophospholipid carriers for herbal drug delivery. The term “Phyto “means “Plant’’, while “some” means “cell” like. Phytosomes  are advanced  microsphere or cell form of herbal product that are better absorbed, utilized to produce better result than those produced by conventional herbal extract. As standardized extracts which are shows, poor bioavailability and limited their clinical utility. Prepared complexation with certain other clinically useful nutrients substantially improved the bioavailability of   extracts. The nutrients so helpful for enhancing the absorption of other nutrients are the phospholipids. [2] Phytosome technology emerged in 1989. [3] Based on a histochemical observation that certain polyphenols had strong bonding affinity for phospholipids in their intact plant tissue. A group of Italian researchers focused on polyphenol preparations known to be poorly bioavailable when taken orally. These were typically mixtures of polyphenols extracted from single plant species, and their conversion into phytosome forms markedly increased their bioavailability.[4]

 

Most of biologically active constituent of plant are polar or water soluble molecule such as flavonoids, tannins, terpenoid etc. are poorly absorbed either due to their large molecular size, multiple ring molecules that are too large to absorb by simple diffusion or due to their poor lipid solubility, severely limiting their ability to pass across the lipid rich biological membrane of erythrocytes of small intestine.[5] Resulting poor bioavailability.[6] The effectiveness of herbal product is depending on delivery and effective level of the active compound.[5] The water soluble phytoconstituent molecule can be converted in to lipid compatible molecular complexes which are called Phytosomes. Phytosomes produce little cell because of that valuable component of herbal extract are protected from destruction by digestive secretion and gut bacteria. It has been also observed that the separation and purification of various component of an extract may lead to a partial loss of specific activity for purified compound. Phytosomes are prepared by complexing the polyphenolic phytoconstituent in the ratio of 1:2 or 1:1 with phosphotidylcholine.[5] Phytosomes are obtained by reacting soya phospholipids with selected botanical derivatives in an aprotic solvent on the basis of their physical, chemical and spectroscopic characteristics. Their sizes vary between 50 nm to a few hundred µm. These complexes can be considered as novel entities. [7] Phytosomes are not liposome’s structural. [8] Phytosomes is unit of few molecules bonded together while liposome’s as an aggregate of many phospholipids molecules but without specially bonding to them. [9] Chemical analysis indicates that in phytosome usually a flavonoid or terpenoid that is polyphenolic molecule linked with at least one phosphotidylcholine molecule. Bond is formed between these two molecules creating a hybrid molecule. Phytosomes are better able to transition from a hydrophilic environment into the lipid-friendly environment of the enterocytes cell membrane. These highly lipid miscible hybrid bond is better suited to merge in the lipid phase of the enterocytes outer cell membrane and finally reaching to blood. [10]

 

As standardized extracts has, poor bioavailability often limited to their clinical utility. By complexation with certain other clinically useful nutrients the bioavailability of such extracts substantially improved. The nutrients so helpful for enhancing the absorption of other nutrients are the phospholipids. The enterocytes outer membrane has a lipid molecular bilayer that consists largely of Phosphotidylcholine.[3] Phospholipids is a principle molecular building block of cell membrane, making up the matrix into which fit a large variety of proteins that are enzymes, transport proteins, receptors, and other biological energy converters. In humans and other higher animals the phospholipids are also employed as natural digestive aids and as carriers for both fat-miscible and water miscible nutrients. They are miscible both in water and in oil/ lipid environments, and are well absorbed orally. Phosphotidylcholine are complex molecules that are used in all known life forms and responsible for formation of cell membrane. [11] They derived from soybean which is miscible both in the water phase and in oil, lipid phases and water it is excellently absorbed when taken orally.[12] Phospholipids are small lipid molecule in which the glycerol is bonded only to two fatty acid instead of three as in triglycerides, and the remaining sites occupied by a phosphate group. The phytosome process has been applied to many popular herbal extract including Ginkgo biloba, Grape seed, Milk thistle, Green tea, Quercetin, Curcumin, Herba Epidemic, Gallic acid and Ginseng. The tannins flavonoid and terpenoid components of these herbal extracts lend themselves quite well for the direct binding to phosphotidylcholine. [9]

 

The aim of the present work is to develop phytosomes from the peels of the pomegranate so that formulation having better bioavailability can be developed.

Fig.1 Fruits and Peels of Pomegranate

 

 

MATERIAL AND METHODS:

Materials:

Phosphotidylcholine obtained as a gift sample by Lipoid; Ludwigshafen, Germany.

 

Collection of Plant:

The Fruit were collected in the month of November to February from the surrounding areas of Aurangabad District, Maharashtra, India. The plant material was identified and authenticated by depositing the herbarium sheet of the plant specimens in Botany Department, Dr. Babasaheb Ambedkar Marathawada   University, Aurangabad, Maharashtra, India. Under the voucher No: Botany/2012-13/81.Accession no.0562.

 

Preparation of the Plant Extract [13]:

Firstly fresh pomegranates (500 gm) were obtained (in order to prepare fresh extraction) and washed with distilled water then peeled and their edible portions were carefully separated. The peels were air dried in a ventilated oven at 40°C for 48 hours. Dried peels are coarsely powdered in an electric grinder and ground to a fine powder and passed through a 24 mesh sieve and stored in plastic bags for the next step. A 100 gm sample of powder was subjected for extraction in Soxhlet extractor using petroleum ether for the removal of fatty content. The mark used for extraction of phenolic content using 200 ml methanol (99.9%) in soxhlet apparatus for 4-6 hrs i.e. 13-14 cycles. Then extract were dissolved in 70% Methanol and Ethyl acetate in separating fennel shake for 30 min. separate the organic layer, excess of ethyl acetate was removed with help of rotary evaporator to produce a dry powder and then subjected to preliminary chemical tests which revealed the presence of polyphenol component in the plant extracts.

 

High Performance Liquid Chromatography (HPLC) of extract:

Polyphenolic content of methanolic extract of pomegranate peels was determined by using HPLC technique and compared with standard.

 

Preparation of Phyto-Phospholipid complex by solvent evaporation method [14]:

Different molar concentration of Methanolic extract and Phosphatidylcholine (1:0.5, 1:1, 1:2) was taken in the beaker. 20 ml methanol was added and placed beaker on magnetic stirrer for 2 hours, then dried in vacuum oven at a temperature below 600C till solvent was evaporated. Prepared phospholipids complex washed with 10 ml N- Hexane with continuous stirring. The Flavonoid–phospholipid complex was precipitated and the precipitate was filtered and dried under vacuum to remove traces of solvents. The resultant phospholipids complex placed in an amber coloured bottle, flushed with nitrogen and stored at room temperature.

 

Evaluation of Phyto Phospholipid Complex:

IR Spectra [15]:

IR spectra of Extract-phospholipid complex were obtained. The IR Spectrum was recorded using % Transmission mode with 4.0 cm-1 resolution and auto gain with HAPP-GENZEL apodization. IR was recorded using detector 1(2.8mm/sec).

 

Differential scanning Calorimetry (DSC) [16]:

The samples were sealed in the aluminum crimp cell and heated at the speed of 100C/min from 0 to 300◦C in nitrogen atmosphere (60 ml/min). The peak transition onset temperature of Extract–phospholipid complex was noted.

 

Scanning Electron Microscope (SEM) [17]:

Surface morphology of complex was investigated by scanning electron microscope model JSM5600 (JEOL).

 

Dissolution Study [18]:

In-vitro drug release of the Phyto-phospholipid complex was conducted using dissolution test apparatus USPXXIII at 50 rpm. The dissolution medium consisted of 900 ml of 6.8 phosphate buffers, temperature maintained at 37±0.50c. Aliqouts of 5 ml were withdrawn at predetermined time intervals and an equivalent amount of fresh dissolution fluid equilibrated at the same temperature was replaced. Aliquots withdrawn were filtered through 0. 45 µm Whatmann filter paper and diluted appropriately with vanillin sulphuric acid. With absorbance measured on a UV- spectrophotometer at 228 nm.

 

Ex-vivo absorption study using everted small intestine sac method [18]:

Intestine of goat (2–2.5 inch piece) was taken, washed, and freed of intestinal contents and everted using a glass rod. One end of the intestine was fastened using thread while a thread-tied cannula was fitted at another end, and kept in PBS solution (pH 7.4). Two flasks were taken, one of which was filled with 50 ml phosphate buffer saline containing methanolic extract (A) and another one with the 50 ml of phosphate buffer saline containing Methanolic extract and phospholipid complex (B); 2.0 ml of mammalian ringer’s solution was injected in each of the two intestine pieces and immersed in the separate flasks containing Methanolic extract (A) and Methanolic extract and phospholipid complex (B) solutions. After the specified time interval the serosal fluid of each intestine fragment was assayed for drug content using a UV spectrophotometer by taking absorbance at 204 nm.

 

RESULT AND DISCUSSION:

Chemical test for Methanolic Extract:

Phytochemical investigation of methanolic extract showed the presence of tannins, flavonoids and other Phenolic compounds.

 

 

 

 

High Performance Liquid Chromatography:

HPLC was carried out for the qualitative estimation of ellagic acid present in the methanolic extract of pomegranate peels. 

Fig 2. HPLC chromatogram of Pomegranate peel extract

 

 

 

 

 

Preparation of Phytosomal complex:

Methanolic extract-phospholipids complex was prepared to improve the lipophilic properties of Methanolic extract. The complex with different ratios of phospholipids and extract such as 0.5, 1, 2 was prepared. The results showed that when the ratio was lower than 1, the stability of the Phyto–phospholipids complex was worse. Stable Phytosomal complex was obtained with Phyto-phospholipids complex with a 1:1 and 1:2 ratios of ingredients. Practical yield was high with ratio 1:2. The obtained complex was used for the subsequent structural analysis.

 

Table 1. Percent practical yield of extract phospholipid complex

S.N.

Ingredients

Quantity(mg)

(concentration)

% yield

1

Methanolic extract

Phosphotidylcholine

834.56

380.45

         80.65

2

Methanolic extract

Phosphotidylcholine

834.56

760.90

         84.26

3

Methanolic extract

Phosphotidylcholine

834.56

1521.8

         87.26

 


Infrared Spectroscopy Study:


 

a) Phosphatidylcholine

Table 2. Prominent peaks of Phosphatidylcholine

S. N.

Wave No

(cm-1)

Functional group

1

2919.7

C-H Stretch

2

1727.91

C=O Aromatic ring

3

1095.37

C-N Primary amine

4

1526.38

N-H Bending

 

 

b) Methanolic extract

Table 3.  Prominent peaks of extract

S.N.

Wave No (cm-1)

Functional group

1

3856.93

N-H Stretch

2

3586.95

OH   Stretch

3

2348.87

OCN group

4

1528.51

N-H Bending

 

 

 

 

 

 

 

                                          

 

C) Physical mixture of Extract and phospholipid

Table 4.  Prominent peaks of physical mixture of extract-phospholipid

S.N.

Wave No (cm-1)

Functional group

1

3853.08

N-H Stretch

2

1712.48

C=O

3

2356.59

OCN

4

3594.66

OH group

 

 

d) Extract Phospholipid complex

Table 5. Prominent peak of extract-phospholipid complex

S. N.

Wave No (cm-1)

Functional group

1

2919.7

C-H

2

1712.48

C=O

3

1025.94

P-O-C

 

Fig.3 IR Spectra a) Phosphotidylcholine b) Methanolic extract c) Physical mixture of Extract and phospholipids d) Extract Phospholipid complex 

 


Differential Scanning Calorimetry (DSC) of the complex:

The DSC thermograms of phospholipids, Methanolic extract, their physical mixture and phospholipids complex were shown in Fig. 4. Phospholipids show two different kinds of endothermal peaks, and the first (74.85°C) end thermal peak appears mild, it was considered that the formation of this peak was due to hot movements of phospholipids molecule polarity parts. However, the second endothermal peak at 190.6◦C appears sharp-pointed; it was considered that owing to the transition from gel state to liquid crystal state, the carbon–hydrogen chain in phospholipids perhaps happened to be melt, isomerous or the crystal changes methanolic extract is not pure, so it shows abroad endothermal peak, and its beginning melting point at 136.5◦C. Physical  mixture of and phospholipids shows that there are two endothermal peaks, and the former is 28.8◦C, the same with the onset temperature of phospholipids complex; another is 136.5C, the same with the onset temperature of Methanolic  extract. It was considered that when the temperature was increased, phospholipids were melt and drugs were dissolved in the phospholipids and partly formed phospholipids complex, which could be explained through the theory of preparation by melt-out method. DSC of phospholipids complex shows the endothermal peaks of drug and phospholipid are disappeared and the phase transition temperature is lower than the phase transition temperature of phospholipids.    

 

After the combination of methanolic extract and the phospholipids molecule polarity parts, the carbon–hydrogen chain in phospholipids could turn freely and enwrap the phospholipids molecule polarity parts, which made the sequence decrease between phospholipids aliphatic hydrocarbon chains, made the second endothermal peak of phospholipids disappear and depressed the phase transition temperature.

 

a) Methanolic extract

b) Phosphatidylcholine

c)  Physical mixture of Extract– phospholipids

 

d)   Extract-phospholipid complex   

 

Fig. 4   DSC Thermograms of a) Methanolic extract   b)  Phosphatidylcholine c) Physical mixture of Extract– phospholipids    d) Extract-phospholipid complex      

 

Scanning Electron Microscopy (SEM)

The surface morphology of phospholipids complex as examined by SEM is Phospholipids complex were made up of phospholipids and drugs and appeared spherical shape when at 200 x magnification, we could see that phospholipids did not exit on the appearance of drugs but drugs uniformly dispersed in phospholipids and formed the structure of spherical shape.

 

Fig. 5 Scanning electron micrographs of phospholipids complex

Spectrophotometric Characterization

Construction of standard graph of Methanolic extract

The absorbance was measured by spectrophotometer at 204 nm using 6.8 pH Buffer      

 

 

Table 6. Absorbance of drug at 204 nm

Sr. No.

Concentration ( µg/ml)

Absorbance

1

0

0

2

10

0.194

3

20

0.428

4

30

0.621

5

40

0.812

6

50

0.984

 

 

Fig. 6 Standard Calibration Curve of phosphate buffer pH 6.8.

               

 

Ex-Vivo Absorption Studies

Table 7. Absorbance of extract Phospholipids complex and plain extract

Sr. No.

ME-Complex (cumulative abs µm)

Extract                   (cumulative abs µm)

1

0

0

2

165

108

3

280

238

4

521

420

5

734

650

6

780

678

 

Fig. 7 Absorption of extract Phospholipid complex and plain extract

The absorption of the Methanolic extract-Phospholipid complex was found to be greater than plain Methanolic extract at different time intervals. The curve between absorption and time for Methanolic extract Phospholipid complex is shown in Fig. 7 which clearly indicates the enhanced absorption of the Methanolic extract-Phospholipid complex.

 

CONCLUSION

In the present study pomegranate peel extracts phospholipid complex were prepared by solvent evaporation   method and   evaluated   by   using   various   physiochemical   parameters. The physiochemical  parameters investigation showed that pomegranate peels formed complex with phosphotidylcholine  with  better  bioavailability.  The  IR,  DSC, SEM  studies confirmed  theformation of complex. The dissolution profile of the complex was found to be improved. Thus, it can be concluded that phospholipid complex of pomegranate peels may be of potential use for improving its bioavailability.

 

ACKNOWLEDGEMENT:       Authors are thankful to the Principal of Dr. Vedprakash Patil Pharmacy College, Georai Tanda, Aurangabad for  providing  necessary facilities and support.  Authors  are also  thankful  to  Lipoi;  Ludwigshafen, Germany  for  supplying  phosphotidylcholine as gift sample.

 

REFERANCES:

1)       Kareparamban JA, et al. Phytosome: A novel revolution  in herbal drugs, International Journal of Research in Pharmacy and Chemistry .  2(2) ; 2012 : 299-310.

2)       www.phospholipidsonline.com

3)       Kidd PM, Phytosome highly available plant extract, Alternative medicine review. 14(3) ; 2009: 226-246.

4)       www.indena.com/pdf/ephytosome.pdf [accessed june20, 2009]

5)       Awasthi R , et al., Phytosome: An  approach to increase  the Bioavailaility of  plant extract ,  International Journal  of  Pharmacy and Pharmaceutical sciences. 3(2);  2011 : 1-3.

6)       Jain N, et al, Phytosome:  A novel drug  delivery  Systemfor  herbal medicie,   International Journal  of  Pharmacy and Drug Research. 2(4); 2010: 224-228.

7)       Dubey D, et al , Phytosomes: herbal formulation.  International Journal  of  Pharmaceutical Research And Developpment . 2(5); 2007:126-132

8)       Jain N K. Controlled and Novel drug delivery, 1st ed., CBS Publication, 2005.

9)       Kumar V, Herbosome a novel carrier for herbal drug delivery, International Journal  of  Pharmaceutical science and Research.(3); 2011: 36 - 41.

10)    Citernesi U and Sciacchitano M, Phospholipids active ingredient complexes Cosmetic and  Toilet preparation, International Journal  of  Pharmaceutical Research. 110(11); 1995: 57-68.

11)    Kareparamban JA, et al.  Phytosome : A novel Revolution inherbal drugs,  International Journal of Research in Pharmacy and Chemistry.2(2);  2012: 299-310.

12)    Thurapati  P R and  Reddy  S M.  Phytosomes:   Novel Phytophospholipid carriers  for herbal drug delivery. International  Journal of Health Research. 2(6); 2011: 28-33.

13)    Abdollahzadeh  V, et al  Antibacteria  and . Antifungal Activities of Punica Granatum Peel Extracts Against Oral Pathogens, Journal  of Dentistry. 8(1); 2011 : 1-6.

14)          Kumawat R S,et al. Preparation, Characterization and Antioxidant Activities of Gallic Acid-Phospholipids Complex.   International Journal  of Research in  Pharmaceutical Science.  2(1); 2012: 138-138.

15)    Semalty A, et al., Development and characterization of aspirin-phospholipid complex for improved drug delivery. International Journal  of  Pharmaceutical Research and Nanotechnology . 3 (2); 2010: 940-947.

16)    Maiti K,et al., Curcumi- Phospholipid complex: Preparation,  therapeutic evaluation and Pharmacokinetic study in rats, International Journal  of  Pharmaceutics. 2007: 155–163.

17)    Yanyu  X, et al. The  preparation  of Silybin phospholipid complex and the study on its pharmacokinetics in rats, International Journal  of  Pharmaceutical..(20)307: 77–82.

18)    Sharma A et.al Complexation with phosphatidylcholine as a  strategy for absorption enhancement of boswellic  acid,  Drug  Delivery. (2010) 17(8): 587–59.